May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Marwan Fakih: Meaningful clinical benefits for KRAS G12C MCRC
Apr 14, 2025, 17:39

Marwan Fakih: Meaningful clinical benefits for KRAS G12C MCRC

Marwan Fakih, Associate Director for Clinical Sciences at City of Hope, shared a post on X about a paper he co-authored with colleagues published in the Journal of Clinical Oncology:

“Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator’s Choice in Chemorefractory KRAS G12C Colorectal Cancer | Journal of Clinical Oncology.

Meaningful clinical benefits for KRAS G12C MCRC!”

“Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator’s Choice in Chemorefractory KRAS G12C Colorectal Cancer”

Authors: Filippo Pietrantonio, Lisa Salvatore, Taito Esaki, Dominik Paul Modest, David Paez Lopez-Bravo, Emily Chan, Joseph Chao, Qui Tran, Chiara Cremolini, Marwan Fakih et al.

Marwan Fakih: Meaningful clinical benefits for KRAS G12C MCRC

More posts featuring Marwan Fakih.